Comparison of the performance characteristics of three generations of membrane oxygenators: Univox®, Univox® Gold™ and SpiralGold™

With continuous enhancement in oxygenator design, the question is raised as to how these changes actually impact the performance of the oxygenator. The recent addition of two new oxygenators by the Bentley Division of Baxter Healthcare Corporation provided us with a unique opportunity to compare the performance of each device and isolate the impact of each design change on performance. While the basic design and flow patterns have remained the same, application of the Duraflo® II treatment has produced the Univox® Gold™ and a change in the fibre-winding technique has produced the SpiralGold™. This study compared the effects of heparin coating (Univox® to Univox® Gold™) and fibre-winding (Univox® Gold™ to SpiralGold™) on gas and heat transfer and resistance to blood flow (pressure drop). Six oxygenators of each model were evaluated utilizing an in vitro single pass circuit, which first conditioned bovine blood to the Association for the Advancement of Medical Instrumentation (AAMI) venous standards. Blood flows of 4.0, 5.0, 6.0 and 7.0 I/min, FiO2 values of 1.0, 0.8 and 0.6, and gas-to-blood flow ratios of 0.5, 1.0 and 1.5 were chosen as test variables. Data generated included oxygen transfer, carbon dioxide transfer, arterial pO2, resistance to blood flow, and coefficient of heat exchange. The results indicate that the Duraflo II treatment does not have a significant effect on gas and heat transfer or resistance to blood flow. The fibre-winding technique employed with the new SpiralGold™, however, has improved significantly gas exchange and arterial PO2 when compared with the previous Univox® models. Resistance to blood flow and coefficient of heat exchange were not affected significantly by the winding technique.

[1]  M. Sakai.  19.3 Cardiopulmonary bypass without systemic heparinization in a dog model , 1997 .

[2]  P D Beckley,et al.  Predicting oxygenator clinical performance from laboratory in-vitro testing. , 1994, The journal of extra-corporeal technology.

[3]  M. Voorhees.  Oxygenator technology: the future , 1994, Perfusion.

[4]  D. Bethune.  Standards for blood gas exchange devices , 1994, Perfusion.

[5]  J. Gaylor,et al.  Membrane oxygenators: influence of design on performance , 1994, Perfusion.

[6]  C. Forbes,et al.  Biomaterials in cardiopulmonary bypass , 1994, Perfusion.

[7]  S. R. Wickramasinghe,et al.  Hollow fiber modules made with hollow fiber fabric , 1993 .

[8]  S. Novikova,et al.  [The gas-exchange properties of membrane blood oxygenators with immobilized heparin]. , 1992, Anesteziologiia i reanimatologiia.

[9]  R H Clayton,et al.  Assessment of oxygen transfer in membrane oxygenators during clinical cardiopulmonary bypass. , 1992, Clinical physics and physiological measurement : an official journal of the Hospital Physicists' Association, Deutsche Gesellschaft fur Medizinische Physik and the European Federation of Organisations for Medical Physics.

[10]  D. W. Fried,et al.  A comparison of two oxygen transfer strategies: Bentley Univox and the Bard HF 5000 , 1992, Perfusion.

[11]  Y. Gu,et al.  Heparin surface treatment does not impair gas and heat transfer of an extracorporeal circuit , 1992 .

[12]  C. Wildevuur,et al.  Clinical experience with heparin-coated cardiopulmonary bypass circuits , 1991, Perfusion.

[13]  L. Hsu.  Principles of heparin-coating techniques , 1991 .

[14]  W. van Oeveren,et al.  Heparin-coating of extracorporea circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass , 1991 .

[15]  S. Épshtein,et al.  Hemodynamic effects of initial anesthesia with benzodiazepine drugs in combination with phentanyl in patients with maxillofacial pathology , 1990 .

[16]  M. Turina,et al.  Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators. , 1989, The Journal of thoracic and cardiovascular surgery.

[17]  M. R. Rolfs,et al.  Evaluation of Duraflo II heparin immobilized cardiopulmonary bypass circuits. , 1990, ASAIO transactions.

[18]  L. V. von Segesser,et al.  Heparin Coated Hollow-Fiber Oxygenator Without Systemic Heparinization in Comparison to Classic Bubble and Membrane Oxygenators , 1988, The Journal of ExtraCorporeal Technology.